Condensed Interim Statements of Changes in Stockholders' Deficiency (Unaudited) - USD ($)	3 Months Ended						9 Months Ended
	Mar. 31, 2024	Dec. 31, 2023	Sep. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Mar. 31, 2024	Mar. 31, 2023
Balance, December 31, 2022	$ (796,260)	$ (784,925)	$ (771,412)	$ (746,717)	$ (744,660)	$ (725,191)	$ (771,412)	$ (725,191)
Net loss	(10,002)	(11,335)	(13,513)	(12,267)	(2,057)	(19,468)	(34,850)	(33,792)
Ending balance	(806,263)	(796,260)	(784,925)	(758,984)	(746,717)	(744,660)	(806,263)	(758,984)
Common Stock [Member]
Balance, December 31, 2022	$ 70	$ 70	$ 70	$ 70	$ 70	$ 70	$ 70	$ 70
Beginning balance, shares	7,070,000	7,070,000	7,070,000	7,070,000	7,070,000	7,070,000	7,070,000	7,070,000
Net loss
Ending balance	$ 70	$ 70	$ 70	$ 70	$ 70	$ 70	$ 70	$ 70
Ending balance, shares	7,070,000	7,070,000	7,070,000	7,070,000	7,070,000	7,070,000	7,070,000	7,070,000
Additional Paid-in Capital [Member]
Balance, December 31, 2022	$ 106,990	$ 106,990	$ 106,990	$ 106,990	$ 106,990	$ 106,990	$ 106,990	$ 106,990
Net loss
Ending balance	106,990	106,990	106,990	106,990	106,990	106,990	106,990	106,990
Retained Earnings [Member]
Balance, December 31, 2022	(903,320)	(891,985)	(878,472)	(853,777)	(851,720)	(832,251)	(878,472)	(832,251)
Net loss	(10,002)	(11,335)	(13,513)	(12,267)	(2,057)	(19,468)
Ending balance	$ (913,323)	$ (903,320)	$ (891,985)	$ (866,044)	$ (853,777)	$ (851,720)	$ (913,323)	$ (866,044)